We are live on ! Find out more
MEDP icon

Medpace

488 hedge funds and large institutions have $5.81B invested in Medpace in 2023 Q3 according to their latest regulatory filings, with 74 funds opening new positions, 154 increasing their positions, 186 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more first-time investments, than exits

New positions opened: 74 | Existing positions closed: 45

5% more funds holding

Funds holding: 464488 (+24)

0% more capital invested

Capital invested by funds: $5.78B → $5.81B (+$26.2M)

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

9% less call options, than puts

Call options by funds: $21.9M | Put options by funds: $24.1M

1.13% less ownership

Funds ownership: 79.19%78.05% (-1.1%)

17% less repeat investments, than reductions

Existing positions increased: 154 | Existing positions reduced: 186

Holders
488
Holders Change
+24
Holders Change %
+5.17%
% of All Funds
7.74%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.13%
New
74
Increased
154
Reduced
186
Closed
45
Calls
$21.9M
Puts
$24.1M
Net Calls
-$2.18M
Net Calls Change
-$10.6M
Name Holding Trade Value Shares
Change
Change in
Stake
VanEck Associates
226
VanEck Associates
New York
$1.44M +$456K +1,783 +43%
LTAS
227
Linden Thomas Advisory Services
North Carolina
$1.44M -$584K -2,282 -28%
RGC
228
Roberts, Glore & Co
Illinois
$1.42M
CS
229
Candriam SCA
Luxembourg
$1.39M -$1.06M -4,144 -42%
VI
230
Vestcor Inc
New Brunswick, Canada
$1.36M +$421K +1,647 +42%
SOMRS
231
State of Michigan Retirement System
Michigan
$1.36M -$128K -500 -8%
ZIM
232
Zacks Investment Management
Illinois
$1.35M -$442K -1,727 -24%
Pacer Advisors
233
Pacer Advisors
Pennsylvania
$1.34M -$219K -857 -13%
AFA
234
Abacus FCF Advisors
Florida
$1.32M -$38.4K -150 -3%
AIM
235
Ausbil Investment Management
Australia
$1.31M +$607K +2,375 +78%
Deutsche Bank
236
Deutsche Bank
Germany
$1.31M +$580K +2,267 +72%
EP
237
Edgestream Partners
New Jersey
$1.31M +$1.38M +5,397 New
PCMU
238
Paragon Capital Management (Utah)
Utah
$1.3M +$1.37M +5,373 New
X
239
Xponance
Pennsylvania
$1.27M -$48.9K -191 -4%
RWA
240
Redhawk Wealth Advisors
Minnesota
$1.27M +$87.2K +341 +7%
AIP
241
Ameritas Investment Partners
Nebraska
$1.26M -$246K -960 -16%
US Bancorp
242
US Bancorp
Minnesota
$1.25M -$90.5K -354 -6%
NMIMC
243
Northwestern Mutual Investment Management Company
Wisconsin
$1.25M -$86.7K -339 -6%
MAM
244
Martingale Asset Management
Massachusetts
$1.24M -$286K -1,118 -18%
NMERB
245
New Mexico Educational Retirement Board
New Mexico
$1.24M
PRC
246
Pearl River Capital
Michigan
$1.23M -$301K -1,177 -19%
SDIC
247
South Dakota Investment Council
South Dakota
$1.22M +$1.29M +5,041 New
Janney Montgomery Scott
248
Janney Montgomery Scott
Pennsylvania
$1.22M -$116K -455 -8%
DFCM
249
Dark Forest Capital Management
Puerto Rico
$1.22M +$103K +402 +9%
CAPTRUST Financial Advisors
250
CAPTRUST Financial Advisors
North Carolina
$1.21M +$372K +1,455 +41%

MEDP Hedge Fund Activity: Q3 2023 in Review

488 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q3 2023, worth a combined $5.81B — up 0.45% from $5.78B a quarter earlier.

Buyers outnumbered sellers: 74 funds opened new MEDP positions and 45 closed out — a net gain of 29 holders — while 154 added to existing stakes and 186 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $81.6M. The largest seller was Millennium Management, cutting an estimated $91.8M.

  • 488 institutional investors held Medpace (MEDP) as of Q3 2023, up from 464 in Q2 2023.
  • Funds reported $5.81B of Medpace stock for Q3 2023, up 0.45% quarter-over-quarter.
  • 74 funds opened new Medpace positions in Q3 2023 and 45 closed out, a net change of +29 holders.
  • The largest Medpace buyer in Q3 2023 was Wellington Management Group, an estimated $81.6M added.
  • The largest Medpace seller in Q3 2023 was Millennium Management, an estimated $91.8M sold.

Based on aggregated 13F filings for Q3 2023.